Differences

This shows you the differences between two versions of the page.

--- shelley_dougan [2022/10/19 00:23]
liam [COVID-19]
+++ shelley_dougan [2022/10/19 00:29] (current)
liam
@@ Line 7: / Line 7: @@
 ===== COVID-19 =====
-Dougan has authored several studies related to [[COVID-19 vaccines]], particularly in regards to their safety in pregnancy and for young children.
+Dougan has authored several studies related to [[COVID-19 vaccines]], particularly in regards to their safety in pregnancy and for young children. She has received funding for some of this research from the [[COVID-19 Immunity Task Force]].((Fell, D. B., Dhinsa, T., Alton, G. D., Török, E., Dimanlig-Cruz, S., Regan, A. K., Sprague, A. E., Buchan, S. A., Kwong, J. C., Wilson, S. E., Håberg, S. E., Gravel, C. A., Wilson, K., El-Chaâr, D., Walker, M. C., Barrett, J., MacDonald, S. E., Okun, N., Shah, P. S., & Dougan, S. D. (2022). //Association of COVID-19 Vaccination in Pregnancy With Adverse Peripartum Outcomes.// JAMA. https://doi.org/10.1001/jama.2022.4255))
   * October 2022: [[https://journals.lww.com/obgynsurvey/Abstract/2022/10000/Association_of_COVID_19_Vaccination_in_Pregnancy.5.aspx|Association of COVID-19 Vaccination in Pregnancy With Adverse Peripartum Outcomes]]
@@ Line 13: / Line 13: @@
     * Lead author is [[Deshayne Fell]], a liaison representative for the [[Canadian Association for Immunization Research, Evaluation and Education]] (CAIRE) on the [[National Advisory Committee on Immunization]] (NACI), responsible for approving COVID-19 vaccines in [[Canada]].((//National Advisory Committee on Immunization (NACI): Membership and representation.// (2020, December 18). Wayback Machine; Government of Canada. https://web.archive.org/web/20201218222110/https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/naci-membership-representation.html))
     * Funded by the [[Public Health Agency of Canada]] (PHAC) through the [[Vaccine Surveillance Reference Group]] and the [[COVID-19 Immunity Task Force]]((Fell, D. B., Dimanlig-Cruz, S., Regan, A. K., Håberg, S. E., Gravel, C. A., Oakley, L., Alton, G. D., Török, E., Dhinsa, T., Shah, P. S., Wilson, K., Sprague, A. E., El-Chaâr, D., Walker, M. C., Barrett, J., Okun, N., Buchan, S. A., Kwong, J. C., Wilson, S. E., & Dunn, S. I. (2022). //Risk of preterm birth, small for gestational age at birth, and stillbirth after covid-19 vaccination during pregnancy: population based retrospective cohort study.// BMJ, 378, e071416. https://doi.org/10.1136/bmj-2022-071416))
+  * May 2022: [[https://www.jogc.com/article/S1701-2163(22)00138-4/fulltext|Peripartum Outcomes Following COVID-19 Vaccination in Late Pregnancy: Findings from a Population-Based Retrospective Cohort Study in Ontario, Canada]]
+    * Co-authored by Fell.((El-Chaâr, D., Dhinsa, T., Alton, G., Torok, E., Dimanlig-Cruz, S., Regan, A., Sprague, A., Buchan, S., Kwong, J., Wilson, S., Haberg, S., Gravel, C., Wilson, K., Walker, M., Barrett, J., MacDonald, S., Okun, N., Shah, P., Dougan, S., & Dunn, S. (2022). //Peripartum Outcomes Following COVID-19 Vaccination in Late Pregnancy: Findings from a Population-Based Retrospective Cohort Study in Ontario, Canada.// Journal of Obstetrics and Gynaecology Canada, 44(5), 607–608. https://doi.org/10.1016/j.jogc.2022.02.040))
+  * May 2022: [[https://jamanetwork.com/journals/jama/fullarticle/2790607|Association of COVID-19 Vaccination in Pregnancy With Adverse Peripartum Outcomes]]